{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T20:19:20Z","timestamp":1705004360404},"reference-count":69,"publisher":"Springer Publishing Company","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neonatal Network"],"published-print":{"date-parts":[[2012]]},"abstract":"<jats:p>Globally, respiratory syncytial virus (RSV) infection causes substantial morbidity in infants and young children, particularly those with specific risk factors (e.g., prematurity, chronic lung and congenital heart disease). Supportive measures are the mainstay of care for RSV-related disease. In the absence of medical treatments, RSV prophylaxis (RSVP) with palivizumab is recommended for high-risk patients to help reduce the risk of developing serious disease. Geographic distances, language and cultural barriers, and other factors can impede effective education of caregivers regarding the potential impact of RSV disease and benefits of RSVP compliance. We present our experiences developing successful Canadian RSVP programs, organized through a dedicated coordinator or small group of health care staff. These programs focus on identifying all infants and young children eligible for RSVP, effectively educating health care staff and family caregivers, developing educational tools that consider language and cultural factors, and interdisciplinary collaboration and networking throughout the health care system.<\/jats:p>","DOI":"10.1891\/0730-0832.31.6.369","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T02:08:11Z","timestamp":1352340491000},"page":"369-386","source":"Crossref","is-referenced-by-count":8,"title":["Identifying and Ensuring Optimal Care for All Children at Risk of Developing Serious Respiratory Syncytial Virus Disease: A Canadian Nurses\u2019 Perspective"],"prefix":"10.1891","volume":"31","author":[{"given":"Marianne","family":"Bracht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie","family":"Basevitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Cranis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Paulley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bosco","family":"Paes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"793","published-online":{"date-parts":[[2012,1,1]]},"reference":[{"issue":"8","key":"2019091813150981000_31.6.369.1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/pch\/14.8.521","article-title":"Prevention of respiratory syncytial virus infection","volume":"14","year":"2009","journal-title":"Paediatr Child Health"},{"issue":"8","key":"2019091813150981000_31.6.369.2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/pch\/16.8.487","article-title":"Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Preventing respiratory syncytial virus infections","volume":"16","year":"2011","journal-title":"Paediatr Child Health"},{"key":"2019091813150981000_31.6.369.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804877"},{"key":"2019091813150981000_31.6.369.4","doi-asserted-by":"publisher","DOI":"10.1067\/S0022-3476(03)00513-4"},{"key":"2019091813150981000_31.6.369.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70133-1"},{"issue":"12","key":"2019091813150981000_31.6.369.6","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/ppul.20507","article-title":"Beyond randomized controlled trials: A \u201creal life\u201d experience of respiratory syncytial virus infection prevention in infancy with and without palivizumab","volume":"41","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"2019091813150981000_31.6.369.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60206-1"},{"key":"2019091813150981000_31.6.369.8","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200109000-00010"},{"key":"2019091813150981000_31.6.369.9","doi-asserted-by":"publisher","DOI":"10.1067\/S0022-3476(03)00510-9"},{"key":"2019091813150981000_31.6.369.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-007-0418-y"},{"key":"2019091813150981000_31.6.369.11","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1993.02160270065020"},{"key":"2019091813150981000_31.6.369.12","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268805005571"},{"key":"2019091813150981000_31.6.369.13","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000137568.71589.bd"},{"key":"2019091813150981000_31.6.369.14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.4.499"},{"key":"2019091813150981000_31.6.369.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.10.042"},{"issue":"3","key":"2019091813150981000_31.6.369.16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ppul.1950070309","article-title":"Clinical characteristics of respiratory syncytial virus infections in healthy versus previously compromised host","volume":"7","year":"1989","journal-title":"Pediatr Pulmonol"},{"key":"2019091813150981000_31.6.369.17","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2008.139188"},{"key":"2019091813150981000_31.6.369.18","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1053\/rmed.2002.1295","article-title":"Risk factors for severe respiratory syncytial virus infection in infants","volume":"96","year":"2002","journal-title":"Respir Med"},{"key":"2019091813150981000_31.6.369.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2009.06.003"},{"key":"2019091813150981000_31.6.369.20","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31805d01e3"},{"key":"2019091813150981000_31.6.369.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198607103150201"},{"key":"2019091813150981000_31.6.369.22","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199309000-00006"},{"key":"2019091813150981000_31.6.369.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2006.03.010"},{"issue":"11","key":"2019091813150981000_31.6.369.24","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/oxfordjournals.aje.a115826","article-title":"Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life","volume":"133","year":"1991","journal-title":"Am J Epidemiol"},{"key":"2019091813150981000_31.6.369.25","doi-asserted-by":"publisher","DOI":"10.1542\/peds.104.4.894"},{"issue":"4","key":"2019091813150981000_31.6.369.26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00431-002-1105-7","article-title":"Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany","volume":"162","year":"2003","journal-title":"Eur J Pediatr"},{"key":"2019091813150981000_31.6.369.27","doi-asserted-by":"publisher","DOI":"10.1067\/S0022-3476(03)00511-0"},{"key":"2019091813150981000_31.6.369.28","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-0059"},{"key":"2019091813150981000_31.6.369.29","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2008.29.3101"},{"key":"2019091813150981000_31.6.369.30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.299.6705.946"},{"key":"2019091813150981000_31.6.369.31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1824-7288-35-11","article-title":"Epidemiological assessment of respiratory syncytial virus infection in hospitalized infants, during the season 2005\u20132006 in Palermo, Italy","volume":"35","year":"2009","journal-title":"Ital J Pediatr"},{"key":"2019091813150981000_31.6.369.32","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.earlhumdev.2011.01.009","article-title":"The multicenter Italian birth cohort study on incidence and determinants of lower respiratory tract infection hospitalization in infants at 33 weeks GA or more: Preliminary results","volume":"87","year":"2011","journal-title":"Early Hum Dev"},{"key":"2019091813150981000_31.6.369.33","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2000.110531"},{"key":"2019091813150981000_31.6.369.34","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.505126"},{"key":"2019091813150981000_31.6.369.35","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200302001-00004"},{"issue":"7","key":"2019091813150981000_31.6.369.36","first-page":"563","article-title":"Hospital admission rates for lower respiratory tract infections in infants in the Northwest Territories and the Kitikmeot region of Nunavut between 2000 and 2004","volume":"12","year":"2007","journal-title":"Paediatr Child Health"},{"issue":"4","key":"2019091813150981000_31.6.369.37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/25761900.2022.12220645","article-title":"Bronchiolitis in Inuit children from a Canadian central arctic community, 1995\u20131996","volume":"60","year":"2001","journal-title":"Int J Circumpolar Health"},{"key":"2019091813150981000_31.6.369.38","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-2345"},{"key":"2019091813150981000_31.6.369.39","unstructured":"US Department of State. Background note: Canada. http:\/\/www.state.gov\/r\/pa\/ei\/bgn\/2089.htm. Accessed September 6, 2011."},{"key":"2019091813150981000_31.6.369.40","unstructured":"World Health Organization. Canada statistics. http:\/\/www.who.int\/countries\/can\/en\/. Accessed September 6, 2011."},{"key":"2019091813150981000_31.6.369.41","unstructured":"Health Canada. First nations, inuit, and aboriginal health. http:\/\/www.hc-sc.gc.ca\/fniah-spnia\/index-eng.php. Accessed May 15, 2012."},{"key":"2019091813150981000_31.6.369.42","doi-asserted-by":"publisher","DOI":"10.1086\/651603"},{"issue":"2","key":"2019091813150981000_31.6.369.43","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1155\/2011\/493056","article-title":"A decade of respiratory syncytial virus epidemiology and prophylaxis: Translating evidence into everyday clinical practice","volume":"18","year":"2011","journal-title":"Can Respir J"},{"key":"2019091813150981000_31.6.369.44","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00032-09"},{"key":"2019091813150981000_31.6.369.45","doi-asserted-by":"publisher","DOI":"10.1542\/peds.102.3.531"},{"key":"2019091813150981000_31.6.369.46","doi-asserted-by":"publisher","DOI":"10.1067\/S0022-3476(03)00454-2"},{"key":"2019091813150981000_31.6.369.47","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31821146f7"},{"key":"2019091813150981000_31.6.369.48","doi-asserted-by":"publisher","DOI":"10.1038\/jp.2008.28"},{"key":"2019091813150981000_31.6.369.49","unstructured":"Synagis (palivizumab). Full Prescribing Information, Abbott Laboratories, Limited, St-Laurent, Quebec, Canada, 2011."},{"key":"2019091813150981000_31.6.369.50","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X08315238"},{"issue":"7","key":"2019091813150981000_31.6.369.51","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1185\/03007990902929112","article-title":"Risk-scoring tool for respiratory syncytial virus prophylaxis in premature infants born at 33\u201335 completed weeks\u2019 gestational age in Canada","volume":"25","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"2019091813150981000_31.6.369.52","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802484234"},{"key":"2019091813150981000_31.6.369.53","doi-asserted-by":"crossref","unstructured":"Sim\u00f5es EA , Carbonell-Estrany X , Fullarton JR , et al.; European RSV Risk Factor Study Group. A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33\u201335 weeks of gestational age, based on data from the Spanish FLIP Study. Respir Res. 2008;9:78.","DOI":"10.1186\/1465-9921-9-78"},{"issue":"1","key":"2019091813150981000_31.6.369.54","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/14767058.2010.482610","article-title":"European risk factors\u2019 model to predict hospitalization of premature infants born 33\u201335 weeks\u2019 gestational age with respiratory syncytial virus: Validation with Italian data","volume":"24","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2019091813150981000_31.6.369.55","doi-asserted-by":"publisher","DOI":"10.1515\/jpm.2010.074"},{"issue":"4","key":"2019091813150981000_31.6.369.56","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/INF.0b013e3181c810da","article-title":"Population based external validation of a European predictive model for respiratory syncytial virus hospitalization of premature infants born 33 to 35 weeks of gestational age","volume":"29","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"2019091813150981000_31.6.369.57","first-page":"833","article-title":"Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations","volume":"171","year":"2011","journal-title":"Eur J Pediatr"},{"issue":"1","key":"2019091813150981000_31.6.369.58","first-page":"46","article-title":"A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis","volume":"16","year":"2010","journal-title":"J Manag Care Pharm"},{"key":"2019091813150981000_31.6.369.59","first-page":"195","article-title":"Compliance with RSV prophylaxis: Global physicians\u2019 perspectives","volume":"3","year":"2009","journal-title":"Patient Prefer Adherence"},{"key":"2019091813150981000_31.6.369.60","doi-asserted-by":"crossref","unstructured":"Bracht M , Basevitz D , Cranis M , Paulley R , Paes B . Practical resources for nurses and other health care providers involved in the care of children at risk for respiratory syncytial virus infection. Neonatal Network. 2012.","DOI":"10.1891\/0730-0832.31.6.387"},{"key":"2019091813150981000_31.6.369.61","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200302001-00007"},{"issue":"1","key":"2019091813150981000_31.6.369.62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.adnc.2004.10.005","article-title":"Development, implementation, and evaluation of a community- and hospital-based respiratory syncytial virus prophylaxis program","volume":"5","year":"2005","journal-title":"Adv Neonatal Care"},{"issue":"1","key":"2019091813150981000_31.6.369.63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.adnc.2004.10.006","article-title":"Family teaching toolbox. Preventing respiratory syncytial virus (RSV) infection","volume":"5","year":"2005","journal-title":"Adv Neonatal Care"},{"key":"2019091813150981000_31.6.369.64","doi-asserted-by":"crossref","unstructured":"Bracht M , Basevitz D , Cranis M , Paulley R , Paes B . Empirical practices for reducing the risk of respiratory syncytial virus infection in infants and young children: A Canadian Nurses\u2019 perspective. Neonatal Network. 2012.","DOI":"10.1891\/0730-0832.31.6.357"},{"key":"2019091813150981000_31.6.369.65","unstructured":"Browne AJ , Fiske JA , Thomas G . First nations women\u2019s encounters with mainstream health care services and systems. 2000. http:\/\/www.cewh-cesf.ca\/PDF\/bccewh\/first-nations-wmens.pdf. Accessed May 15, 2012."},{"issue":"2","key":"2019091813150981000_31.6.369.66","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/01.inf.0000110271.48794.a7","article-title":"Factors impacting compliance with palivizumab prophylaxis","volume":"23","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"2019091813150981000_31.6.369.67","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/14767050600591290","article-title":"A 4-year survey on palivizumab respiratory syncytial virus (RSV)-prophylaxis: How can compliance be improved?","volume":"19","year":"2006","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"2019091813150981000_31.6.369.68","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/ANC.0b013e318225a2c2","article-title":"Procedural pain management for neonates using nonpharmacological strategies: Part 1: Sensorial interventions","volume":"11","year":"2011","journal-title":"Adv Neonatal Care:"},{"issue":"5","key":"2019091813150981000_31.6.369.69","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/ANC.0b013e318229aa76","article-title":"Procedural pain management for neonates using nonpharmacological strategies: Part 2: Mother-driven interventions","volume":"11","year":"2011","journal-title":"Adv Neonatal Care"}],"container-title":["Neonatal Network"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1891\/0730-0832.31.6.369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T17:08:29Z","timestamp":1687799309000},"score":1,"resource":{"primary":{"URL":"http:\/\/connect.springerpub.com\/lookup\/doi\/10.1891\/0730-0832.31.6.369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":69,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,1,1]]},"published-print":{"date-parts":[[2012]]}},"alternative-id":["10.1891\/0730-0832.31.6.369"],"URL":"https:\/\/doi.org\/10.1891\/0730-0832.31.6.369","relation":{},"ISSN":["0730-0832","1539-2880"],"issn-type":[{"value":"0730-0832","type":"print"},{"value":"1539-2880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}